Research on the Development and Validation of an Early Prediction Model for Delirium

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRuijin Hospital

About this trial

Delirium has a high incidence rate and significantly affects patient prognosis. Diagnosis often relies on manual assessment, which is subject to strong subjectivity, high rates of missed diagnosis, and poor stability. This study employs non-contact identification technology based on machine vision analysis to quantitatively analyze characteristic biological feature data such as micro-expressions. It then investigates the correlation between these features and delirium subtypes. By integrating clinical phenotypic data and using machine learning algorithms, a multi-modal early prediction model for delirium is constructed to meet the clinical need for early warning of delirium subtypes and enhance the efficacy of delirium identification.

Eligibility criteria

Qualifiers

Age ≥ 18 years, expected ICU stay ≥ 24 hours, and informed consent to participate in this study;

Disqualifiers

Patients with severe facial trauma/deformities that prevent complete expression acquisition, and patients with a history of emotional problems (such as anxiety, depression, etc.).

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

795 Participants
are grouped into 2 trial groups

Locations

This trial has no locations

Sponsors and collaborators